{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:33:38Z","timestamp":1792089218596,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.lfs.2024.123312","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:02:49Z","timestamp":1734048169000},"page":"123312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Efficacy of lipid nanoparticles-based vaccine to protect against vulvovaginal candidiasis (VVC): Implications for women's reproductive health"],"prefix":"10.1016","volume":"361","author":[{"given":"Masood Alam","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman M.","family":"Mousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa Essa","family":"Alradhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Allemailem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.123312_bb0005","first-page":"211","article-title":"Predisposing factors endorsing Candida infections","volume":"23","author":"Singh","year":"2015","journal-title":"Infez. Med."},{"key":"10.1016\/j.lfs.2024.123312_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11046-014-9749-1","article-title":"Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment","volume":"177","author":"Martins","year":"2014","journal-title":"Mycopathologia"},{"key":"10.1016\/j.lfs.2024.123312_bb0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2340\/00015555-1194","article-title":"Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species","volume":"92","author":"Martins","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.lfs.2024.123312_bb0020","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","article-title":"Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species","volume":"7","author":"Whaley","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2024.123312_bb0025","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to azoles and echinocandins worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.lfs.2024.123312_bb0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrmicro2636","article-title":"Growth of Candida albicans hyphae","volume":"9","author":"Sudbery","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2024.123312_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pathogens8020053","article-title":"Candida albicans interactions with mucosal surfaces during health and disease","volume":"8","author":"Nikou","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.lfs.2024.123312_bb0040","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bmj.328.7451.1306","article-title":"ABC of sexually transmitted infections: vaginal discharge\u2014causes, diagnosis, and treatment","volume":"328","author":"Mitchell","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.lfs.2024.123312_bb0045","article-title":"Epidemiology, risk factors and antimicrobial profile of vulvovaginal candidiasis (VVC): a study among women in the central region of Saudi Arabia","volume":"31","author":"Venugopal","year":"2021","journal-title":"J. Mycol. M\u00e9dicale"},{"key":"10.1016\/j.lfs.2024.123312_bb0050","first-page":"86","article-title":"Vulvovaginal candidiasis among women in Makkah city, Saudi Arabia","volume":"7","author":"Faidah","year":"2013","journal-title":"Res. J. Med. Sci."},{"key":"10.1016\/j.lfs.2024.123312_bb0055","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1128\/IAI.70.9.4791-4797.2002","article-title":"Immune cell-mediated protection against vaginal candidiasis: evidence for a major role of vaginal CD4(+) T cells and possible participation of other local lymphocyte effectors","volume":"70","author":"Santoni","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.123312_bb0060","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1128\/iai.65.8.3399-3405.1997","article-title":"Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats","volume":"65","author":"De Bernardis","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.123312_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.68.3.1649-1654.2000","article-title":"Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody","volume":"68","author":"Han","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.123312_bb0070","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1128\/IAI.70.5.2725-2729.2002","article-title":"Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis","volume":"70","author":"De Bernardis","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.123312_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.micinf.2007.01.012","article-title":"Murine model of concurrent oral and vaginal Candida albicans colonization to study epithelial host-pathogen interactions","volume":"9","author":"Rahman","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.lfs.2024.123312_bb0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/13693780701883508","article-title":"Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis","volume":"46","author":"Raska","year":"2008","journal-title":"Med. Mycol."},{"key":"10.1016\/j.lfs.2024.123312_bb0085","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1128\/IAI.71.9.5273-5279.2003","article-title":"A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. Albicans activities","volume":"71","author":"Moragues","year":"2003","journal-title":"Infect. Immun."},{"issue":"52","key":"10.1016\/j.lfs.2024.123312_bb0090","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.123312_bb0095","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(89)90197-7","article-title":"Phase II study of D.651, an oral vaccine designed to prevent recurrences of vulvovaginal candidiasis","volume":"7","author":"Levy","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.123312_bb0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/MMBR.62.1.130-180.1998","article-title":"Cell wall and secreted proteins of Candida albicans: identification, function, and expression","volume":"62","author":"Chaffin","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.lfs.2024.123312_bb0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3314\/jjmm.41.219","article-title":"Protective antigens and mechanisms of anti-Candida immunity","volume":"41","author":"Antonio","year":"2000","journal-title":"Nippon Ishinkin Gakkai Zasshi"},{"key":"10.1016\/j.lfs.2024.123312_bb0110","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1128\/IAI.00669-08","article-title":"A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine production","volume":"76","author":"Pietrella","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.lfs.2024.123312_bb0115","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1016\/j.vaccine.2011.05.066","article-title":"Escheriosome mediated cytosolic delivery of Candida albicans cytosolic proteins induces enhanced cytotoxic T lymphocyte response and protective immunity","volume":"29","author":"Chauhan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2024.123312_bb0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/vaccines9090949","article-title":"Role of NKT cells during viral infection and the development of NKT cell-based nanovaccines","volume":"9","author":"Khan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.123312_bb0125","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3390\/pharmaceutics14071357","article-title":"Safety and prophylactic efficacy of liposome-based vaccine against the drug-resistant Acinetobacter baumannii in mice","volume":"14","author":"Khan","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2024.123312_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.102124","article-title":"Encapsulation of MERS antigen into \u03b1-GalCer-bearing-liposomes elicits stronger effector and memory immune responses in immunocompetent and leukopenic mice","volume":"34","author":"Khan","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.lfs.2024.123312_bb0135","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/1061186X.2022.2066681","article-title":"Delivery of MERS antigen encapsulated in \u03b1-GalCer-bearing liposomes elicits stronger antigen-specific immune responses","volume":"30","author":"Khan","year":"2022","journal-title":"J. Drug Target."},{"key":"10.1016\/j.lfs.2024.123312_bb0140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2147\/IDR.S305503","article-title":"Coadministration of ginger extract and fluconazole shows a synergistic effect in the treatment of drug-resistant vulvovaginal candidiasis","volume":"14","author":"Khan","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.lfs.2024.123312_bb0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/antibiotics9060312","article-title":"Candidiasis and mechanisms of antifungal resistance","volume":"9","author":"Bhattacharya","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.lfs.2024.123312_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12951-017-0319-9","article-title":"Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines","volume":"15","author":"De Serrano","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.lfs.2024.123312_bb0155","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.4049\/jimmunol.172.9.5269","article-title":"IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating fc gamma receptors","volume":"172","author":"Getahun","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2024.123312_bb0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.actbio.2016.05.001","article-title":"Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis","volume":"39","author":"Carneiro","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.lfs.2024.123312_bb0165","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/vaccines9101159","article-title":"The role of B-cells and antibodies against Candida vaccine antigens in invasive candidiasis","volume":"9","author":"Shukla","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.lfs.2024.123312_bb0170","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1567-1364.2010.00620.x","article-title":"Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes","volume":"10","author":"De Bernardis","year":"2010","journal-title":"FEMS Yeast Res."},{"key":"10.1016\/j.lfs.2024.123312_bb0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11046-023-00819-w","article-title":"Anti-Candida antibodies of patients with invasive candidiasis inhibit growth, alter cell wall structure, and kill Candida albicans in vitro","volume":"189","author":"Carrano","year":"2024","journal-title":"Mycopathologia"},{"key":"10.1016\/j.lfs.2024.123312_bb0180","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/microorganisms11051211","article-title":"The interplay between Candida albicans, vaginal mucosa, host immunity and resident microbiota in health and disease: an overview and future perspectives","volume":"11","author":"Gaziano","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.lfs.2024.123312_bb0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrmicro.2017.107","article-title":"Development and regulation of single- and multi-species Candida albicans biofilms","volume":"16","author":"Lohse","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.lfs.2024.123312_bb0190","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.3390\/ijms23115895","article-title":"Virulence factors of Candida spp. and host immune response important in the pathogenesis of vulvovaginal candidiasis","volume":"23","author":"Czechowicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123312_bb0195","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftx127","article-title":"Anti-biofilm activity of antibody directed against surface antigen complement receptor 3-related protein-comparison of Candida albicans and Candida dubliniensis","volume":"76","author":"Chup\u00e1cov\u00e1","year":"2018","journal-title":"Pathog Dis."},{"issue":"Pt 12","key":"10.1016\/j.lfs.2024.123312_bb0200","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1099\/jmm.0.2008\/001479-0","article-title":"Antibody response to the 45 kDa Candida albicans antigen in an animal model and potential role of the antigen in adherence","volume":"57","author":"Bujd\u00e1kov\u00e1","year":"2008","journal-title":"J. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123312_bb0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11274-014-1760-7","article-title":"A monoclonal antibody against 47.2 kDa cell surface antigen prevents adherence and affects biofilm formation of Candida albicans","volume":"31","author":"Mishra","year":"2015","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"11","key":"10.1016\/j.lfs.2024.123312_bb0210","doi-asserted-by":"crossref","first-page":"e7967","DOI":"10.1371\/journal.pone.0007967","article-title":"Characterization of mucosal Candida albicans biofilms","volume":"4","author":"Dongari-Bagtzoglou","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.123312_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.692491","article-title":"It takes two to tango: how a dysregulation of the innate immunity, coupled with Candida virulence, triggers VVC onset","volume":"12","author":"Ardizzoni","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.lfs.2024.123312_bb0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/antiox11020178","article-title":"Therapeutic potential of perillaldehyde in ameliorating vulvovaginal candidiasis by reducing vaginal oxidative stress and apoptosis","volume":"11","author":"Chen","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.lfs.2024.123312_bb0225","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/infdis\/jiaa444","article-title":"An exaggerated monocyte-derived cytokine response to Candida hyphae in patients with recurrent vulvovaginal candidiasis","volume":"225","author":"Rosati","year":"2022","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2024.123312_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.959740","article-title":"Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis","volume":"13","author":"Ge","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123312_bb0235","doi-asserted-by":"crossref","first-page":"iqae010","DOI":"10.1093\/oxfimm\/iqae010","article-title":"Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology","volume":"5","author":"Cheng","year":"2024","journal-title":"Oxf Open Immunol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:42:48Z","timestamp":1736185368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524009020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":47,"alternative-id":["S0024320524009020"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123312","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of lipid nanoparticles-based vaccine to protect against vulvovaginal candidiasis (VVC): Implications for women's reproductive health","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123312"}}